Proneuron

Mobilizing the immune system to treat spinal cord injuries

GizaVC invests in the vision of Israel's most innovative entrepreneurs.

About

Proneuron harnesses the power of the body's own immune system for treating debilitating central nervous system (CNS) disorders. It focuses on cell therapy and neuroimmunology for treating spinal cord injuries as well as other neurological disorders that, until recently, were considered incurable.

pronureon c

 

Founders

 Dr. Adrian Harel, Prof. Michal Schwartz

Management

Chairman: Nathan Hevrony

Giza's Team Member

Zvi Schechter

 

 

Fields of invesment: icon lifeHealthcare

Contact info: Website